159 related articles for article (PubMed ID: 7644100)
1. Erythropoietin and the anaemia of chronic disease.
Krantz SB
Nephrol Dial Transplant; 1995; 10 Suppl 2():10-7. PubMed ID: 7644100
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
[TBL] [Abstract][Full Text] [Related]
3. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
[TBL] [Abstract][Full Text] [Related]
4. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
6. The future of r-HuEPO.
Eschbach JW
Nephrol Dial Transplant; 1995; 10 Suppl 2():96-109. PubMed ID: 7644114
[TBL] [Abstract][Full Text] [Related]
7. Current and potential applications for erythropoietin.
Pedrazzini A
Acta Haematol; 1992; 87 Suppl 1():2-3. PubMed ID: 1574962
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
Abels RI
Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
[TBL] [Abstract][Full Text] [Related]
9. The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).
Rose EH; Abels RI; Nelson RA; McCullough DM; Lessin L
Br J Haematol; 1995 Apr; 89(4):831-7. PubMed ID: 7772519
[TBL] [Abstract][Full Text] [Related]
10. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
12. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis.
Nordström D; Lindroth Y; Marsal L; Hafström I; Henrich C; Rantapää-Dahlqvist S; Engström-Laurent A; Fyhrquist F; Friman C
Rheumatol Int; 1997; 17(2):67-73. PubMed ID: 9266623
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
Erslev AJ
Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
Abels RI
Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.
Pangalis GA; Poziopoulos C; Angelopoulou MK; Siakantaris MP; Panayiotidis P
Br J Haematol; 1995 Mar; 89(3):627-9. PubMed ID: 7734364
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.
Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ
Ann Rheum Dis; 1996 Oct; 55(10):739-44. PubMed ID: 8984939
[TBL] [Abstract][Full Text] [Related]
17. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
James RD; Wilkinson PM; Belli F; Welch R; Cowan R
Acta Haematol; 1992; 87 Suppl 1():12-5. PubMed ID: 1574960
[TBL] [Abstract][Full Text] [Related]
19. The application of recombinant erythropoietin in anemic patients with cancer.
Spivak JL
Semin Oncol; 1992 Jun; 19(3 Suppl 8):25-8. PubMed ID: 1615336
[TBL] [Abstract][Full Text] [Related]
20. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
